Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313367257> ?p ?o ?g. }
- W4313367257 endingPage "170" @default.
- W4313367257 startingPage "151" @default.
- W4313367257 abstract "We have developed and characterized a novel D2R antagonist with exceptional GPCR selectivity - ML321. In functional profiling screens of 168 different GPCRs, ML321 showed little activity beyond potent inhibition of the D2R and to a lesser extent the D3R, demonstrating excellent receptor selectivity. The D2R selectivity of ML321 may be related to the fact that, unlike other monoaminergic ligands, ML321 lacks a positively charged amine group and adopts a unique binding pose within the orthosteric binding site of the D2R. PET imaging studies in non-human primates demonstrated that ML321 penetrates the CNS and occupies the D2R in a dose-dependent manner. Behavioral paradigms in rats demonstrate that ML321 can selectively antagonize a D2R-mediated response (hypothermia) while not affecting a D3R-mediated response (yawning) using the same dose of drug, thus indicating exceptional in vivo selectivity. We also investigated the effects of ML321 in animal models that are predictive of antipsychotic efficacy in humans. We found that ML321 attenuates both amphetamine- and phencyclidine-induced locomotor activity and restored pre-pulse inhibition (PPI) of acoustic startle in a dose-dependent manner. Surprisingly, using doses that were maximally effective in both the locomotor and PPI studies, ML321 was relatively ineffective in promoting catalepsy. Kinetic studies revealed that ML321 exhibits slow-on and fast-off receptor binding rates, similar to those observed with atypical antipsychotics with reduced extrapyramidal side effects. Taken together, these observations suggest that ML321, or a derivative thereof, may exhibit ″atypical″ antipsychotic activity in humans with significantly fewer side effects than observed with the currently FDA-approved D2R antagonists." @default.
- W4313367257 created "2023-01-06" @default.
- W4313367257 creator A5009435611 @default.
- W4313367257 creator A5010424086 @default.
- W4313367257 creator A5010533046 @default.
- W4313367257 creator A5013971949 @default.
- W4313367257 creator A5018880670 @default.
- W4313367257 creator A5019300147 @default.
- W4313367257 creator A5019664768 @default.
- W4313367257 creator A5022343281 @default.
- W4313367257 creator A5025947629 @default.
- W4313367257 creator A5032524322 @default.
- W4313367257 creator A5033249270 @default.
- W4313367257 creator A5034202004 @default.
- W4313367257 creator A5048984594 @default.
- W4313367257 creator A5050828839 @default.
- W4313367257 creator A5057954581 @default.
- W4313367257 creator A5060113662 @default.
- W4313367257 creator A5061998470 @default.
- W4313367257 creator A5076880355 @default.
- W4313367257 creator A5088907157 @default.
- W4313367257 date "2022-12-30" @default.
- W4313367257 modified "2023-10-14" @default.
- W4313367257 title "Identification and Characterization of ML321: A Novel and Highly Selective D<sub>2</sub> Dopamine Receptor Antagonist with Efficacy in Animal Models That Predict Atypical Antipsychotic Activity" @default.
- W4313367257 cites W1498704357 @default.
- W4313367257 cites W1833104430 @default.
- W4313367257 cites W1858777777 @default.
- W4313367257 cites W187595635 @default.
- W4313367257 cites W1925492557 @default.
- W4313367257 cites W1972278987 @default.
- W4313367257 cites W1972931244 @default.
- W4313367257 cites W1975667546 @default.
- W4313367257 cites W1975691556 @default.
- W4313367257 cites W1988821183 @default.
- W4313367257 cites W1989793475 @default.
- W4313367257 cites W1992156446 @default.
- W4313367257 cites W2005756201 @default.
- W4313367257 cites W2029915913 @default.
- W4313367257 cites W2034475831 @default.
- W4313367257 cites W2036386823 @default.
- W4313367257 cites W2060872117 @default.
- W4313367257 cites W2066414494 @default.
- W4313367257 cites W2068057735 @default.
- W4313367257 cites W2069849124 @default.
- W4313367257 cites W2070753604 @default.
- W4313367257 cites W2074631079 @default.
- W4313367257 cites W2080192851 @default.
- W4313367257 cites W2082956345 @default.
- W4313367257 cites W2087688448 @default.
- W4313367257 cites W2090979638 @default.
- W4313367257 cites W2096037950 @default.
- W4313367257 cites W2097744565 @default.
- W4313367257 cites W2099576957 @default.
- W4313367257 cites W2127680534 @default.
- W4313367257 cites W2129321699 @default.
- W4313367257 cites W2137727336 @default.
- W4313367257 cites W2147476077 @default.
- W4313367257 cites W2151088690 @default.
- W4313367257 cites W2400469798 @default.
- W4313367257 cites W2426254068 @default.
- W4313367257 cites W2562170296 @default.
- W4313367257 cites W2606634315 @default.
- W4313367257 cites W2703970226 @default.
- W4313367257 cites W2735454576 @default.
- W4313367257 cites W2752517690 @default.
- W4313367257 cites W2753967614 @default.
- W4313367257 cites W2760367307 @default.
- W4313367257 cites W2765153686 @default.
- W4313367257 cites W2785023044 @default.
- W4313367257 cites W2801704870 @default.
- W4313367257 cites W2886576780 @default.
- W4313367257 cites W2903176273 @default.
- W4313367257 cites W2963864951 @default.
- W4313367257 cites W2975385530 @default.
- W4313367257 cites W2984394901 @default.
- W4313367257 cites W3002566379 @default.
- W4313367257 cites W3005368593 @default.
- W4313367257 cites W3014602173 @default.
- W4313367257 cites W3017499952 @default.
- W4313367257 cites W3097098834 @default.
- W4313367257 cites W3127467109 @default.
- W4313367257 cites W4226444220 @default.
- W4313367257 cites W4282976066 @default.
- W4313367257 cites W4294127798 @default.
- W4313367257 cites W4295539761 @default.
- W4313367257 cites W4296031100 @default.
- W4313367257 cites W50693228 @default.
- W4313367257 doi "https://doi.org/10.1021/acsptsci.2c00202" @default.
- W4313367257 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36654757" @default.
- W4313367257 hasPublicationYear "2022" @default.
- W4313367257 type Work @default.
- W4313367257 citedByCount "1" @default.
- W4313367257 countsByYear W43133672572023 @default.
- W4313367257 crossrefType "journal-article" @default.
- W4313367257 hasAuthorship W4313367257A5009435611 @default.
- W4313367257 hasAuthorship W4313367257A5010424086 @default.
- W4313367257 hasAuthorship W4313367257A5010533046 @default.
- W4313367257 hasAuthorship W4313367257A5013971949 @default.